TECHNOLOGY
Emerging MAPK-targeted Therapies for Melanoma Beyond BRAF V600
New developments in melanoma treatment focus on targeting MAPK pathways, especially for cases not involving BRAF V600 mutations.
New developments in melanoma treatment focus on targeting MAPK pathways, especially for cases not involving BRAF V600 mutations.
Paweł Basta outlined the advancements in robotic surgery and the evolving strategies in treating cancers like ovarian and endometrial, emphasizing patient-centered care.
Udaipur, August 21: A three-day national conference, ‘Trends of Transformation in Oncology – OncoConverge 2026’, began in Udaipur on Friday. On the…